Table 1

Characteristics of the study population according to the presence of sarcopaenia

CharacteristicsTotal sample
n=354
Sarcopaenia
n=103
No sarcopaenia
n=251
p Value
Age (years), median (range)84.2 (80–102)87.5 (800–100)83.2 (80–102)<0.001
Gender, n (%)
 Women236 (67)71 (30)165 (70)0.32
 Men118 (33)32 (27)86 (73)
Education (years), mean±SD5.1±1.65.2±1.75.0±1.60.29
CPS score, median (range)0.4 (0–6)0.7 (0–6)0.3 (0–6)0.001
ADL score, median (range)0.4 (0–7)0.9 (0–7)0.2 (0–7)<0.001
IADL score, median (range)2.5 (0–7)4.0 (0–7)1.9 (0–7)<0.001
BMI (kg/m2), mean±SD25.6±4.523.1±3.926.6±4.3<0.001
Alcohol abuse, n (%)43 (12)11 (11)32 (13)0.36
Current smoking, n (%)6 (2)1 (0)5 (3)0.26
Diseases, n (%)
 Ischaemic heart disease42 (12)11 (11)31 (12)0.40
 CHF20 (6)9 (9)11 (4)0.09
 Hypertension257 (72)68 (67)189 (76)0.07
 Diabetes mellitus103 (29)35 (34)68 (27)0.12
 COPD49 (14)19 (18)30 (12)0.07
 Parkinson's disease6 (2)3 (3)3 (1)0.23
 Cancer17 (5)4 (4)13 (5)0.41
 Osteoarthritis69 (19)20 (19)49 (19)0.55
 Depression90 (25)30 (29)60 (24)0.18
Number of diseases, mean±SD2.1±1.22.2±1.12.1±1.30.44
Haematological parameters
 CRP (mg/dL), mean±SD4.1±3.44.7±4.03.8±3.10.04
 IL-6 (pg/mL), mean±SD2.9±2.53.5±2.82.6±2.40.002
 TNF-α (pg/mL) mean±SD1.9±2.22.2±1.91.8±2.30.09
  • ADL, activities of daily living; BMI, body mass index; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; CPS, Cognitive Performance Scale; CRP, C reactive protein; IADL, instrumental ADL; IL-6, interleukin 6; TNF-α, tumour necrosis factor α.